An NS-segment exonic splicing enhancer regulates influenza A virus replication in mammalian cells

Nature Communications

Volumn 8, Issue , 2017, Pages

  Huang, Xiaofeng ^a,b   Zheng, Min ^a,b   Wang, Pui ^a,b   Mok, Bobo Wing Yee ^a,b   Liu, Siwen ^a,b   Lau, Siu Ying ^a   Chen, Pin ^a,b   Liu, Yen Chin ^a,b   Liu, Honglian ^a,b   Chen, Yixin ^c   Song, Wenjun ^a,d   Yuen, Kwok Yung ^a,b   Chen, Honglin ^a,b,c  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c XIAMEN UNIVERSITY   (China)

^d JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; REGULATOR PROTEIN; VIRAL PROTEIN; INS1 PROTEIN, INFLUENZA VIRUS; NS2 PROTEIN, INFLUENZA VIRUS A; VIRUS RNA;

CELLS AND CELL COMPONENTS; GENE EXPRESSION; GENETIC ANALYSIS; INFLUENZA; MAMMAL; PROTEIN; VIRUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; EXON; GENE EXPRESSION; GENETIC ANALYSIS; INFLUENZA A (H7N9); INFLUENZA A VIRUS (H7N9); MAMMAL CELL; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VIRUS GENE; VIRUS REPLICATION; VIRUS VIRULENCE; A-549 CELL LINE; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; INFLUENZA; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H9N2); METABOLISM; RNA SPLICING; VIROLOGY;

AVES; INFLUENZA A VIRUS; MAMMALIA; ORTHOMYXOVIRIDAE;

A549 CELLS; ENHANCER ELEMENTS, GENETIC; EXONS; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA, HUMAN; RNA SPLICING; RNA, MESSENGER; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 85016033453     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14751     Document Type: Article

References (60)

1. Shih, S. R. & Krug, R. M. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells. EMBO J. 15, 5415-5427 (1996).
2. Fournier, G. et al. Recruitment of RED-SMU1 complex by influenza A Virus RNA polymerase to control viral mRNA splicing. PLoS Pathog. 10, e1004164 (2014).
3. Tsai, P. L. et al. Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. PLoS Pathog. 9, e1003460 (2013).
4. Dubois, J., Terrier, O. & Rosa-Calatrava, M. Influenza viruses and mRNA splicing: doing more with less. MBio 5, e00070-14 (2014).
5. Karlas, A. et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463, 818-822 (2010).
6. Inglis, S. C., Barrett, T., Brown, C. M. & Almond, J. W. The smallest genome RNA segment of influenza virus contains two genes that may overlap. Proc. Natl Acad. Sci. USA 76, 3790-3794 (1979).
7. Lamb, R. A. & Choppin, P. W. Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc. Natl Acad. Sci. USA 76, 4908-4912 (1979).
8. Lamb, R. A. & Lai, C. J. Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell 21, 475-485 (1980).
9. Zheng, M. et al. An A14U substitution in the 3′ noncoding region of the M segment of viral RNA Supports replication of influenza virus with an NS1 deletion by modulating alternative splicing of M segment mRNAs. J. Virol. 89, 10273-10285 (2015).
10. Garaigorta, U. & Ortin, J. Mutation analysis of a recombinant NS replicon shows that influenza virus NS1 protein blocks the splicing and nucleocytoplasmic transport of its own viral mRNA. Nucleic Acids Res. 35, 4573-4582 (2007).
11. Plotch, S. J. & Krug, R. M. In vitro splicing of influenza viral NS1 mRNA and NS1-beta-globin chimeras: possible mechanisms for the control of viral mRNA splicing. Proc. Natl Acad. Sci. USA 83, 5444-5448 (1986).
12. Robb, N. C., Jackson, D., Vreede, F. T. & Fodor, E. Splicing of influenza A virus NS1 mRNA is independent of the viral NS1 protein. J. Gen. Virol. 91, 2331-2340 (2010).
13. Krug, R. M. Functions of the influenza A virus NS1 protein in antiviral defense. Curr. Opin. Virol. 12C, 1-6 (2015).
14. Hale, B. G., Randall, R. E., Ortin, J. & Jackson, D. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89, 2359-2376 (2008).
15. Inglis, S. C. & Brown, C. M. Differences in the control of virus mRNA splicing during permissive or abortive infection with influenza A (fowl plague) virus. J. Gen. Virol. 65(Pt 1): 153-164 (1984).
16. Papasaikas, P. & Valcarcel, J. The spliceosome: the ultimate RNA chaperone and sculptor. Trends Biochem. Sci. 41, 33-45 (2016).
17. Fortes, P., Beloso, A. & Ortin, J. Influenza virus NS1 protein inhibits premRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 13, 704-712 (1994).
18. Lu, Y., Qian, X. Y. & Krug, R. M. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev. 8, 1817-1828 (1994).
19. Backstrom Winquist, E. et al. Inefficient splicing of segment 7 and 8 mRNAs is an inherent property of influenza virus A/Brevig Mission/1918/1 (H1N1) that causes elevated expression of NS1 protein. Virology 422, 46-58 (2012).
20. Chua, M. A., Schmid, S., Perez, J. T., Langlois, R. A. & Tenoever, B. R. Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection. Cell Rep. 3, 23-29 (2013).
21. Chen, Y. et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381, 1916-1925 (2013).
22. Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368, 1888-1897 (2013).
23. To, K. K., Chan, J. F., Chen, H., Li, L. & Yuen, K. Y. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis. 13, 809-821 (2013).
24. Ma, C. et al. Emergence and evolution of H10 subtype influenza viruses in poultry in China. J. Virol. 89, 3534-3541 (2015).
25. Shi, Y. et al. Structures and receptor binding of hemagglutinins from humaninfecting H7N9 influenza viruses. Science 342, 243-247 (2013).
26. Watanabe, T. et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501, 551-555 (2013).
27. Zaraket, H. et al. Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck. Nat. Commun. 6, 6553 (2015).
28. Song, W. et al. The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication. Nat. Commun. 5, 5509(2014)
29. Pu, J. et al. Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proc. Natl Acad. Sci. USA 112, 548-553 (2015).
30. Butt, K. M. et al. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J. Clin. Microbiol. 43, 5760-5767 (2005).
31. Shimizu, K., Handa, H., Nakada, S. & Nagata, K. Regulation of influenza virus RNA polymerase activity by cellular and viral factors. Nucleic Acids Res. 22, 5047-5053 (1994).
32. Robb, N. C. et al. The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes. J. Virol. 85, 5228-5231 (2011).
33. Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q. & Krainer, A. R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568-3571 (2003).
34. Cartegni, L. & Krainer, A. R. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet. 30, 377-384 (2002).
35. Mor, A. et al. Influenza virus mRNA trafficking through host nuclear speckles. Nat. Microbiol. 1, 16069 (2016).
36. Fu, X. D. & Ares, Jr. M. Context-dependent control of alternative splicing by RNA-binding proteins. Nat. Rev. Genet. 15, 689-701 (2014).
37. Zuo, P. & Manley, J. L. The human splicing factor ASF/SF2 can specifically recognize pre-mRNA 5′ splice sites. Proc. Natl Acad. Sci. USA 91, 3363-3367 (1994).
38. Krainer, A. R., Conway, G. C. & Kozak, D. The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites. Cell 62, 35-42 (1990).
39. Daubner, G. M., Clery, A., Jayne, S., Stevenin, J. & Allain, F. H. A syn-anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well. EMBO J. 31, 162-174 (2012).
40. Wang, W. et al. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5, 195-205 (1999).
41. Lin, L. et al. Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. J. Virol. 86, 1942-1954 (2012).
42. Qiu, Y. & Krug, R. M. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 68, 2425-2432 (1994).
43. Satterly, N. et al. Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl Acad. Sci. USA 104, 1853-1858 (2007).
44. Robb, N. C. & Fodor, E. The accumulation of influenza A virus segment 7 spliced mRNAs is regulated by the NS1 protein. J. Gen. Virol. 93, 113-118 (2012).
45. Li, Y., Yamakita, Y. & Krug, R. M. Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc. Natl Acad. Sci. USA 95, 4864-4869 (1998).
46. Selman, M., Dankar, S. K., Forbes, N. E., Jia, J. J. & Brown, E. G. Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing. Emerg. Microbes Infect. 1, e42 (2012).
47. Shih, S. R., Nemeroff, M. E. & Krug, R. M. The choice of alternative 5′ splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex. Proc. Natl Acad. Sci. USA 92, 6324-6328 (1995).
48. Bier, K., York, A. & Fodor, E. Cellular cap-binding proteins associate with influenza virus mRNAs. J. Gen. Virol. 92, 1627-1634 (2011).
49. van Wielink, R. et al. Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells. J. Virol. 86, 12341-12350 (2012).
50. Robb, N. C., Smith, M., Vreede, F. T. & Fodor, E. NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J. Gen. Virol. 90, 1398-1407 (2009).
51. Manz, B., Brunotte, L., Reuther, P. & Schwemmle, M. Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nat. Commun. 3, 802 (2012).
52. Bullido, R., Gomez-Puertas, P., Saiz, M. J. & Portela, A. Influenza A virus NEP (NS2 protein) downregulates RNA synthesis of model template RNAs. J. Virol. 75, 4912-4917 (2001).
53. Morens, D. M., Taubenberger, J. K. & Fauci, A. S. H7N9 avian influenza A virus and the perpetual challenge of potential human pandemicity. MBio 4, e00445-13 (2013).
54. Lam, T. T. et al. Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature 522, 102-105 (2015).
55. Neumann, G., Macken, C. A. & Kawaoka, Y. Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses. J. Virol. 88, 4877-4896 (2014).
56. Liu, M. et al. Genetic diversity of avian influenza A (H10N8) virus in live poultry markets and its association with human infections in China. Sci. Rep. 5, 7632 (2015).
57. Bi, Y. et al. Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe 20, 810-821 (2016).
58. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl Acad. Sci. USA 97, 6108-6113 (2000).
59. Reed, L. J. & Muench, H. A simple method for estimating fifty percent endpoints. Am.J. Hygiene 27, 493-497 (1938).
60. Kakugawa, S., Shimojima, M., Neumann, G., Goto, H. & Kawaoka, Y. RuvB-like protein 2 is a suppressor of influenza A virus polymerases. J. Virol. 83, 6429-6434 (2009).